Eiko Takano1,2, Mathieu Maltais3,4,5, Izumi Kondo6, Yves Rolland3,7. 1. Gérontopôle de Toulouse, Institut du Vieillissement, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Toulouse, France. eikoath@ncgg.go.jp. 2. Center of Assistive Robotics and Rehabilitation for Longevity and Good Health, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan. eikoath@ncgg.go.jp. 3. Gérontopôle de Toulouse, Institut du Vieillissement, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Toulouse, France. 4. Faculté de Médecine Et Sciences de La Santé Centre de Recherche Sur Le Vieillissement, Sherbrooke, QC, Canada. 5. Faculté Des Sciences de L'Activité Physique, Université de Sherbrooke, Sherbrooke, QC, Canada. 6. Center of Assistive Robotics and Rehabilitation for Longevity and Good Health, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan. 7. UMR INSERM 1027, University of Toulouse III, Toulouse, France.
Abstract
PURPOSE: This study examined the bidirectional relationship between depressive symptoms and physical performance in community-dwelling older people with subjective memory complaints. METHODS: Secondary analyses using data from the Multidomain Alzheimer Preventive Trial (MAPT) study were performed. The participants were 1679 subjects (female, 64.8%; mean age, 75.3 ± 4.4 years). The outcome measures were depressive symptoms assessed by the 15-item Geriatric Depression Scale (GDS) and physical performance assessed by the Short Physical Performance Battery (SPPB) and handgrip strength (HGS). All measurements were performed at baseline and at 6, 12, 24, and 36 months. The bidirectional relationships of GDS with SPPB and HGS were examined using mixed-effect regression analysis. RESULTS: Baseline physical performance was significantly associated with a decreased GDS score (SPPB score: β = - 0.210, 95% confidence interval [CI], - 0.283 to - 0.137; HGS: β = - 0.038, 95% CI - 0.056 to - 0.019). The baseline GDS score was significantly associated with decreased physical performance (SPPB score: β = - 0.082, 95% CI - 0.107 to - 0.056; HGS: β = - 0.261, 95% CI - 0.370 to - 0.152). CONCLUSION: Since depressive symptoms and physical performance had a bidirectional relationship, prevention or improvement of decreased physical performance could play a role in reducing depressive symptoms, and addressing depressive symptoms may play a role in improving physical performance. TRIAL REGISTRATION NUMBER: NCT01513252.
PURPOSE: This study examined the bidirectional relationship between depressive symptoms and physical performance in community-dwelling older people with subjective memory complaints. METHODS: Secondary analyses using data from the Multidomain Alzheimer Preventive Trial (MAPT) study were performed. The participants were 1679 subjects (female, 64.8%; mean age, 75.3 ± 4.4 years). The outcome measures were depressive symptoms assessed by the 15-item Geriatric Depression Scale (GDS) and physical performance assessed by the Short Physical Performance Battery (SPPB) and handgrip strength (HGS). All measurements were performed at baseline and at 6, 12, 24, and 36 months. The bidirectional relationships of GDS with SPPB and HGS were examined using mixed-effect regression analysis. RESULTS: Baseline physical performance was significantly associated with a decreased GDS score (SPPB score: β = - 0.210, 95% confidence interval [CI], - 0.283 to - 0.137; HGS: β = - 0.038, 95% CI - 0.056 to - 0.019). The baseline GDS score was significantly associated with decreased physical performance (SPPB score: β = - 0.082, 95% CI - 0.107 to - 0.056; HGS: β = - 0.261, 95% CI - 0.370 to - 0.152). CONCLUSION: Since depressive symptoms and physical performance had a bidirectional relationship, prevention or improvement of decreased physical performance could play a role in reducing depressive symptoms, and addressing depressive symptoms may play a role in improving physical performance. TRIAL REGISTRATION NUMBER: NCT01513252.
Authors: Rachel A Murphy; Ashley K Hagaman; Ilse Reinders; Jeremy A Steeves; Anne B Newman; Susan M Rubin; Suzanne Satterfield; Stephen B Kritchevsky; Kristine Yaffe; Hilsa N Ayonayon; Daniel S Nagin; Eleanor M Simonsick; Brenda W J H Penninx; Tamara B Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-13 Impact factor: 6.053
Authors: Pilar Laborde-Lahoz; Renée El-Gabalawy; Jolene Kinley; Paul D Kirwin; Jitender Sareen; Robert H Pietrzak Journal: Int J Geriatr Psychiatry Date: 2014-10-23 Impact factor: 3.485
Authors: M Luppa; C Sikorski; T Luck; L Ehreke; A Konnopka; B Wiese; S Weyerer; H-H König; S G Riedel-Heller Journal: J Affect Disord Date: 2010-12-30 Impact factor: 4.839